March 2009

ClearTrial Appoints New COO

Friday, March 27, 2009

ClearTrial, a provider of clinical trial software, appointed Michael Bruns as the company’s new chief operating officer. Bruns will oversee ClearTrial’s global operations and help further develop and implement the company’s growth strategy. Prior to joining ClearTrial, Bruns was director of the Technology Investment Banking Group at Robert W. Baird, a global investment banking firm.

[Read More]

WuXi Revenues Up 87% in 2008

Thursday, March 26, 2009

Chinese contract research organization (CRO) WuXi Pharmatech reported an 87% increase in 2008 revenues compared with 2007, with net revenues for continuing operations of $253.5 million. Fourth-quarter 2008 net revenues from continuing operations increased 74% to $64.4 million compared with fourth quarter 2007. The CRO’s non-GAAP net income for 2008 was $58.3 million, up 31% from $44.6 million in 2007.

[Read More]

Oracle to Acquire Relsys

Wednesday, March 25, 2009

Business software company Oracle has agreed to acquire Relsys, a provider of drug safety and risk management applications, for an undisclosed amount. The deal is expected to close by summer.

[Read More]